How much funding has REGiMMUNE Limited. raised?

REGiMMUNE Limited. has raised $24.4M in total funding, most recently a Series D round.

Who are REGiMMUNE Limited.'s investors?

REGiMMUNE Limited.'s investors include Japan Asia Investment Corporation, Nippon Investment & Fi, SMBC Venture Capital Co., Ltd., DBJ Capital Corporation.

When was REGiMMUNE Limited. founded?

REGiMMUNE Limited. was founded in 2006.

Where is REGiMMUNE Limited. headquartered?

REGiMMUNE Limited. is headquartered in Tokyo, Japan.

What industry is REGiMMUNE Limited. in?

REGiMMUNE Limited. operates in Biotech, Healthcare.

How many employees does REGiMMUNE Limited. have?

REGiMMUNE Limited. has 1-10 employees.

REGiMMUNE Limited.

Tokyo, Japan · Founded 2006 · $24.4M raised

Biotech

Healthcare

Headquarters: Tokyo
Employees: 1–10
Founded: 2006
Business Model: B2B

Website: regimmune.com
Total Funding: $24.4M
Last Round: $9.2M Series DFeb 2007
Rounds: 4

About

REGiMMUNE is a clinical-stage biopharmaceutical company focused on creating innovative immunotherapies by harnessing the power of regulatory T cells (Tregs) to induce antigen-specific immune tolerance or anti-tumor responses. Founded in 2006 in Japan and reorganized as REGiMMUNE Limited (Taiwan) as its holding entity, the company is advancing a pipeline of therapeutic candidates targeting graft-versus-host disease (GvHD), autoimmune disorders including Type 1 diabetes, and oncology. REGiMMUNE's proprietary liposome-based platform enables precision modulation of the immune system to treat rare and life-threatening conditions where conventional therapies fall short.

Summary

REGiMMUNE Limited. is a Biotech company based in Tokyo, Japan, founded in 2006. It has raised $24.4M in total across 4 rounds, most recently a $9.2M Series D round in Feb 2007. Investors include Japan Asia Investment Corporation, Nippon Investment & Fi and SMBC Venture Capital Co., Ltd..